CYCLOMETHICONE
- Molecular Weight: 0
- MDL number: MFCD01771102
What is CYCLOMETHICONE?
The Uses of CYCLOMETHICONE
cyclomethicone provides a silky, smooth feel to skin care products, and is considered a non-comedogenic emollient. This is a form of silicone that can deliver active ingredients and also serve as a vehicle for delivering fragrance.
The Uses of CYCLOMETHICONE
Pharmaceutic aid (wetting agent).
brand name
VS-7158 (Witco); VS-7207 (Witco); VS-7349 (Witco).
Safety information for CYCLOMETHICONE
New Products
4,4-Difluoropiperidine hydrochloride tert-butyl 9-methoxy-3-azaspiro[5.5]undecane-3-carboxylate Indole Methyl Resin N-Isopropylurea N,N-Dicyclohexylcarbodiimide(DCC) MELDRUMS ACID 5-METHYLISOXAZOLE-4-CARBOXYLIC ACID Magnessium Bis glycinate Zinc ascorbate 1-bromo-2-butyne 2-acetamidophenol 9(10H)-anthracenone Erythrosin B, 4-Piperidinopiperidine 2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile 2,4-dihydroxybenzaldehyde 3-(4-morpholinophenylamino)-5-amino-1H-pyrazole-4-carbonitrile Methyl 2-methylquinoline-6-carboxylate 2,6-dichloro-4-nitropyridine 4-Bromo-2-chlorobenzonitrile 2-(benzylamino)acetic acid hydrochloride 4-(tert-Butoxycarbonylamino)but- 2-ynoic acid 3,4-dihydro-2H-benzo[b][1,4]dioxepine 1-Phenyl-1-cycloprppanecarboxylicacidYou may like
-
Cyclomethicone, Packaging Size: 50 kgView Details
556-67-2 -
CyclomethiconeView Details
556-67-2 -
Cyclomethicone Liquid Cosmetic gradeView Details
556-67-2 -
CyclomethiconeView Details
556-67-2 -
3-(4-amino-1-oxoisoindolin-2-yl)-1-methylpiperidine-2,6-dione 98%View Details -
20677-73-0 (2,2-diethoxyethyl)methylamine 98%View Details
20677-73-0 -
3-(4-(hydroxyamino)-1-oxoisoindolin-2-yl)piperidine-2,6-dione 98%View Details -
57381-49-4 2-bromo-4-chlorobenzonitrile 98%View Details
57381-49-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
